Network Meta-Analysis
Overview
Authors
Affiliations
There are often multiple potential interventions to treat a disease; therefore, we need a method for simultaneously comparing and ranking all of these available interventions. In contrast to pairwise meta-analysis, which allows for the comparison of one intervention to another based on head-to-head data from randomized trials, network meta-analysis (NMA) facilitates simultaneous comparison of the efficacy or safety of multiple interventions that may not have been directly compared in a randomized trial. NMAs help researchers study important and previously unanswerable questions, which have contributed to a rapid rise in the number of NMA publications in the biomedical literature. However, the conduct and interpretation of NMAs are more complex than pairwise meta-analyses: there are additional NMA model assumptions (i.e., network connectivity, homogeneity, transitivity, and consistency) and outputs (e.g., network plots and surface under the cumulative ranking curves [SUCRAs]). In this chapter, we will: (1) explore similarities and differences between pairwise and network meta-analysis; (2) explain the differences between direct, indirect, and mixed treatment comparisons; (3) describe how treatment effects are derived from NMA models; (4) discuss key criteria predicating completion of NMA; (5) interpret NMA outputs; (6) discuss areas of ongoing methodological research in NMA; (7) outline an approach to conducting a systematic review and NMA; (8) describe common problems that researchers encounter when conducting NMAs and potential solutions; and (9) outline an approach to critically appraising a systematic review and NMA.
Comparative efficacy of leading COVID-19 vaccines: A network meta-analysis.
Rai S, Tripathi S Indian J Med Res. 2025; 161(1):9-20.
PMID: 40036106 PMC: 11878698. DOI: 10.25259/IJMR_750_2024.
Su H, Xiao S, Liang Z, Xun T, Zhang J, Yang X Front Pharmacol. 2025; 15:1475222.
PMID: 39911832 PMC: 11794990. DOI: 10.3389/fphar.2024.1475222.
Chen Z, Chen X, Li D, Jian J, Yao C, Wei X BMC Urol. 2025; 25(1):19.
PMID: 39875945 PMC: 11776312. DOI: 10.1186/s12894-024-01675-6.
Veroniki A, Hutton B, Stevens A, McKenzie J, Page M, Moher D JBI Evid Synth. 2025; 23(3):517-526.
PMID: 39829235 PMC: 11892999. DOI: 10.11124/JBIES-24-00308.
Liang W, Huang S, Huang Y, Huang M, Li C, Liang Y Front Oncol. 2024; 14:1453338.
PMID: 39723374 PMC: 11668658. DOI: 10.3389/fonc.2024.1453338.